GSK343, an inhibitor of EZH2, mitigates fibrosis and inflammation mediated by HIF-1α in human peritoneal mesothelial cells treated with high glucose
Qinglian Wang, Liang Xu, Xian‐Zheng Zhang, Dan Liu, Rong Wang
Topics & Concepts
EZH2Mesothelial CellFibrosisCancer researchInflammationChemistryBiologyGene expressionImmunologyMedicineGeneInternal medicinePathologyBiochemistryMicroRNA in disease regulationHydrogen's biological and therapeutic effectsEpigenetics and DNA Methylation